Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol
2021 · Journal of the American College of Cardiology · 131 citations
https://doi.org/10.1016/j.jacc.2021.04.102
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
206
Citations
2
h-index
2
i10-index
Ulf Landmesser is an academic researcher from Deutsches Herzzentrum der Charité. The author has contributed to research in topics: Diabetes, Cardiovascular Risks, and Lipoproteins & Lipoproteins and Cardiovascular Health & Adipokines, Inflammation, and Metabolic Diseases. The author has an h-index of 2, co-authored 3 publications.
https://doi.org/10.1016/j.jacc.2021.04.102
https://doi.org/10.1016/j.ahj.2025.03.019
Click to start Chat